Boston Scientific accounts are for healthcare professionals only.
Intera 3000™ Hepatic Artery Infusion Pump
Reimbursement
Configure or select a product to continue to order
- Overview
- Ordering information
- HCP resources
- Patient resources
- Select use with Floxuridine
A powerful liver-directed treatment for patients with CRLM and iCCA
HAI therapy exposes tumors in the liver to up to 400x greater drug concentration than systemic infusion while minimizing systemic exposure.1
The HAI pump continuously perfuses the entire liver, allowing patients to maintain their quality of life.2
1. Ensminger WD, Gyves JW. Semin Oncol. 1983;10(2):176-8
2. Ensminger WD, et al. Cancer Res. 1978;38(11 Pt 1):3784-92.
Ordering information
Product Number | Material Description | Unit of Measure |
AP-03000H | Hepatic Artery Infusion Pump | Each |
AP-07014US | HAI Pump Refill Kit | Each |
AP-07004 | HAI Pump Operating Room Prep Kit | Each |
AP-04030 | Non-Coring Refill Needle, 2 IN, 15PK | Box - 15 |
AP-04013-5 | Special Bolus Needle, 1 3/8 IN, 5PK | Box - 5 |
AP-04032-5 | Special Bolus Needle, 2 IN, 5PK | Box - 5 |
IP-37957 | HAI Tapered Catheter | Each |
81643-9270-1 | FLOXURIDINE FOR INJECTION, USP | Each |
From clinical summaries and data presentation templates, to patient education and program support, we are committed to helping support your HAI Therapy program.
View HAI instructions for use and other resources. HAI resource portal
Program support
Resources designed to support institutions providing HAI therapy
Clinical data
Clinical summary series: HAI Therapy for CRLM and iCCA
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy
Cowzer D et al. 2024
Taken together, results of the prospective phase II study and retrospective analysis of routine clinical care underscore the ability of HAI to achieve durable long-term disease control and prolonged survival in patients with advanced, unresectable iCCA.
Clinical summary series: HAI Therapy for CRLM and iCCA
Hepatic arterial infusion pump chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma—PUMP-2 trial
Franssen S, et al. 2025
A multicenter trial from the Netherlands—the PUMP-2 study—has shown remarkable survival benefits for patients with unresectable intrahepatic cholangiocarcinoma (iCCA) confined to the liver.
Clinical summary series: HAI Therapy for CRLM and iCCA
Combined hepatic arterial infusion pump and systemic chemotherapy in the modern era for chemotherapy-naïve patients with unresectable colorectal liver metastases
Verheij FS, et. al., 2023
This single-center retrospective cohort study showed that chemotherapy-naïve patients with unresectable colorectal liver metastases (CRLM) who received HAI + systemic chemotherapy had a high rate of conversion to resection or complete response, which was associated with prolonged survival.
Clinical summary series: HAI Therapy for CRLM and iCCA
Hepatic arterial infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
Holster JJ, et. al., 2022
This systematic review of 9 publications demonstrated HAI was associated with substantial improvement in survival for unresectable intrahepatic cholangiocarcinoma (iCCA) patients.
From treatment journey guides and patient FAQs, to appointment checklists and educational videos, these resources are designed to support conversations with patients and caregivers about HAI Therapy.
Patient resources
Comprehensive patient resources covering HAI Therapy and living with the Intera 3000™ HAI Pump.
Patient testimonials
Real patients. Real results. Learn how HAI Therapy has helped patients reclaim their lives.
HAI therapy: Patient medley video
Hope's story: Stage 4 colorectal cancer
Marsha's story: Stage 4 colon cancer
Rick's story: Bile duct cancer survivor
Thomas' story: Stage 4 colorectal cancer
Patient animation
Watch how the Intera 3000(tm) HAI Pump delivers treatment directly to tumors in the liver.
What is HAI therapy?
JND Therapeutics, Inc. is the U.S. distributor of Floxuridine for Injection, USP. Floxuridine for Injection, USP is for intra-arterial infusion only.